Tectonic Therapeutic, Inc. (TECX) stock
TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$21.96−0.01 (-0.05%)
Close on Nov 11, 2026Market cap $429.30MP/E –Yield 0.00%
Tectonic Therapeutic enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Tectonic Therapeutic's enterprise value was $195.34M on Nov 11, 2026, against $132.78M a year earlier. Over the last 5 years it ranged from -$173.54M to $639.17M, with a median of $12.13M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $195.34M | +60.2% |
| 2025 | Dec 31, 2025 | $121.92M | -76.6% |
| 2024 | Dec 31, 2024 | $521.66M | +3737.5% |
| 2023 | Dec 29, 2023 | $13.59M | – |
| 2022 | Dec 30, 2022 | -$90.55M | – |
| 2021 | Dec 31, 2021 | -$146.14M | – |
| 2020 | Dec 31, 2020 | -$52.49M | -1960.2% |
| 2019 | Dec 31, 2019 | $2.82M | – |
| 2018 | Dec 31, 2018 | -$8.49M | – |
See a number that looks wrong?